0001729427 1 2026-05-15 2026-05-15 0001729427 2026-05-15 2026-05-15 iso4217:USD pure shares S-3 EX-FILING FEES 0001729427 N/A N/A S-3 CNS Pharmaceuticals, Inc. false Equity Common Stock, $0.001 par value per share true 9793479 4.8075 47082150.29 0.0001381 6502.05 47082150.29 6502.05 0.00 6502.05 Pursuant to Rule 416 under the Securities Act, the securities being registered hereunder for the Selling Shareholders include such indeterminate number of additional shares of common stock as may be issued after the date hereof as a result of stock splits, stock dividends or similar transactions.<br/><br/>Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) of the Securities Act of 1933, as amended, based upon the average of the high and low prices for a share of the registrant’s common stock as reported on the Nasdaq Capital Market on May 18, 2026.<br/><br/>Consists of 650,000 shares of common stock and 9,143,479 shares of common stock issuable upon exercise of Pre-Funded Warrants, which shares are offered for resale by the Selling Shareholders named in the prospectus.